Abstract
BackgroundCoronavirus Disease 2019 (COVID-19) is a pandemic affecting all countries in the world. Italy has been particularly afflicted by the health emergency, and since the peak phase has passed, major concern regarding medium to long term complications due to COVID-19 is arising. Little is known in literature regarding thromboembolic complications once healed after COVID-19.Case presentationA 51-year-old patient recovered from COVID-19 pneumonia complicated by pulmonary embolism (PE) came to the hospital for palpitations and chest pain. Although he was on treatment dose of direct oral anticoagulation (DOAC), massive recurrent PE was diagnosed.ConclusionIn the early post COVID-19 era, the question remains regarding the efficacy of DOACs in COVID-19 patients.
Highlights
Coronavirus Disease 2019 (COVID-19) is a pandemic affecting all countries in the world
In the early post COVID-19 era, the question remains regarding the efficacy of direct oral anticoagulation (DOAC) in COVID-19 patients
If on the one hand it is reassuring that new cases are decreasing, and the patients recovered are clearly increasing, on the other hand it is worrisome to assist to unexpected medium-term complications
Summary
Coronavirus Disease 2019 (COVID-19) is a pandemic affecting all countries in the world. Conclusion: In the early post COVID-19 era, the question remains regarding the efficacy of DOACs in COVID-19 patients. Background Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) caused by COVID-19 is a pandemic affecting all countries in the world [1].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
